High-throughput nuclear magnetic resonance metabolomic footprinting for tissue engineering

Tissue Engineering - Part C: Methods

Volumn 14, Issue 2, 2008, Pages 107-118

  Seagle, Christopher ^a   Christie, Megan A ^b   Winnike, Jason H ^a   McClelland, Randall E ^b   Ludlow, John W ^c   O'Connell, Thomas M ^d   Gamcsik, Michael P ^a   Macdonald, Jeffrey M ^a,d  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b ADMET Technologies Inc   (United States)

^c Tengion Inc   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMS; MAGNETIC FIELDS; MAGNETISM; MICROFLUIDICS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RESONANCE; STABILIZERS (AGENTS); TECHNOLOGY; THROUGHPUT; TISSUE CULTURE; TISSUE ENGINEERING;

3 DIMENSIONAL; BIOARTIFICIAL LIVER (BAL); FOOT PRINTING; HIGH-THROUGHPUT (HT); MAGNETIC (CE); MEDIA COMPONENTS; SPIN LATTICES;

MAGNETIC RESONANCE;

ALANINE; ALCOHOL; AMINO ACID; COLLAGEN TYPE 1; GLUCOSE; GLUTAMINE; LACTIC ACID; MATRIGEL; PYRUVIC ACID; UREA;

ARTICLE; BACTERIUM CULTURE; BIOARTIFICIAL LIVER; BIOREACTOR; HUMAN; HUMAN CELL; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; QUALITY CONTROL; SIGNAL NOISE RATIO; TISSUE ENGINEERING;

EID: 45249114418     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2007.0401     Document Type: Article

References (34)

1. O'Leary DJ, Hawkes SP, Wade CG. Indirect monitoring of carbon-13 metabolism with NMR analysis of perfusate with a closed-loop flow system. Magn Reson Med 5, 572, 1987.
2. Bell J. Brown, JC, Sandler, PJ. NMR studies of body fluids. NMR Biomed 2, 242, 1989.
3. Dabos KJ, Parkinson JA, Hewage C, Nelson LJ, Sadler IH, Hayes PC, Plevris JN. H NMR spectroscopy as a tool to evaluate key metabolic functions of primary porcine hepatocytes after cryopreservation. NMR Biomed 15, 241, 2002.
4. Mendes P. Emerging bioinformatics for the metabolome. Brief Bioinform 3, 134, 2002.
5. Allen J, Hassanein, T, Bhatia, SN. Advances in bioartificial liver devices. Hepatology 34, 447, 2001.
6. Holmes E. Nicholls AW, Lindon JC, Connor SC, Connelly JC, Haselden JN, Damment SJ, Spraul M, Neidig P, Nicholson JK. Chemometric models for toxicity classification based on NMR spectra of biofluids. Chem Res Toxicol 13, 471, 2000.
7. Pham-Tuan H, Kaskavelis L, Daykin CA, Janssen HG. Method development in high-performance liquid chromatography for high-throughput profiling and metabonomic studies of biofluid samples. J Chrom B 789, 283, 2003.
8. Kell DB. Metabolomics and systems biology: making sense of the soup. Current Opin Microbiol 7, 296, 2004.
9. Allen J. Davey, HM, Broadhurst, D, Heald, JK, Rowland, JJ, Oliver, SG, Kell, DB, High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat Biotechnol 21, 6926, 2003.
10. Kuesel AC, Graschew G, Hull W, Lorenz W, Thielmann HW. 31P NMR studies of cultured human tumor cells. Influence of pH on phospholipid metabolite levels and the detection of cytidine 5′-diphosphate choline. NMR Biomed 3, 78, 1990.
11. Miccheli AT, Miccheli A, Di Clemente R, Valerio M, Coluccia P, Bizzarri M, Conti F. NMR-based metabolic profiling of human hepatoma cells in relation to cell growth by culture media analysis. Biochim Biophys Acta 1760, 1723, 2006.
12. Bubb W, Wright, LC, Cagney, M, Santangelo, RT, Sorrell, TC, Kuchel, PW. Heteronuclear NMR studies of metabolites produced by Cryptococcus neoformans in culture media: identification of possible virulence factors. Magn Reson Med 42, 442, 1999.
13. Nicholson JK, Lindon JC, Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181, 1999.
14. Holmes E, Nicholson JK, Tranter G. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. Chem Res Toxicol 14, 182, 2001.
15. Gillies RJ. Nuclear magnetic resonance and its applications to physiological problems. Ann Rev Physiol 54, 733, 1992.
16. Macdonald JM, Grillo M, Schmidlin O, Tajiri DT, James TL. NMR spectroscopy and MRI investigation of a potential bioartificial liver. NMR Biomed 11, 55, 1998.
17. Kell D, Brown M, Davey HM, Dunn WB, Spasic I, Oliver SG. Metabolic footprinting and systems biology: the medium is the message. Nat Rev Micro 3, 557, 2005.
18. Kriat M, Confort-Gouny S, Vion-Dury J, Sciaky M, Viout P, Cozzone P. Quantitation of metabolites in human blood serum by proton magnetic resonance spectroscopy. A comparative study of the use of formate and TSP as concentration standards. NMR Biomed 5, 179, 1992.
19. Wolfe SP, Hsu E, Reid LM, Macdonald JM. A novel multicoaxial hollow fiber bioreactor for adherent cell types. Part 1: Hydrodynamic studies. Biotechn Bioengin 77, 83, 2002.
20. Macdonald JMWS, Roy-Chowdhury I, Kubota H, Reid LM. Effect of flow configuration and membrane characteristics on membrane fouling in a novel multicoaxial hollow-fiber bioartificial liver. Ann NY Acad Sci 944, 334, 2001.
21. Macdonald JM, Wolfe SP. Bioreactor design and process for engineering tissue from cells. U.S. Patent 6,979,308, 2005.
22. Macdonald JM, Xu A, Kubota H, LeCluyse E, Hamilton G, Liu H, Rong Y, Moss N, Lodestro C, Luntz T, Wolfe SP, Reid LM. Liver cell culture and lineage biology. In: Atala A, Lanza RP, Vacanti, J.P. eds. Methods of Tissue Engineering. Boston: Academic Press, 2002, pp. 151-195.
23. McClelland RE, Coger RN. Effects of enhanced O2 transport on hepatocytes packed within a bioartificial liver device. Tissue Eng 10, 253, 2004.
24. Gadian DG. NMR and Its Applications to Living Systems, 2nd Ed. New York: Oxford University Press 1995.
25. Lehninger AL, Nelson DL, Cox MM. Lehninger Principles of Biochemistry, 4th Ed. New York: W.H. Freeman, 2005.
26. Weljie AM, Newton J, Mercier P, Carlson E, Slupsky CM. Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem 78, 4430, 2006.
27. Maniara G, Cepriano A, Powell, ML. Method performance and validation for quantitative analysis by 1H and 31P NMR spectroscopy. Applications to analytical standards and agricultural chemicals. Anal Chem 70, 4921, 1998.
28. Macdonald JM, Griffin J, Kubota H, Griffith L, Fair J, Reid LM. Therapeutics. In: Kuhtreiber W, Lanza RP, Chick WL, eds. Cell Encapsulation Technology and Therapeutics. Boston: Birkhauser 1999.
29. Bailey JE, Ollis DF. Biochemical Engineering Fundamentals, 2nd Ed. New York: McGraw-Hill 1986.
30. Zhou FB, Zeng A, Yuan JA. A macrokinetic model for myeloma cell culture based on stoichiometric balance. Biotechnol Appl Biochem 46, 85, 2007.
31. Mancuso A, Sharfstein SA, Fernandez EJ, Clark DS, Blanch HW. Effect of extracellular glutamine concentration on primary and secondary metabolism of a murine hybridoma: an in vivo 13C nuclear magnetic resonance study. Biotech Bioengin 57, 172, 1998.
32. Lieber CS. Metabolism of alcohol. Clin Liver Dis 9, 1, 2005.
33. Nicholas PC, Kim D, Crews FT, Macdonald JM. 1H NMR-based metabolomic analysis of liver, serum and brain following ethanol administration in rats. Che. Res. Tox. 21(2): 408-20, 2008.
34. Guthke R, Zeilinger K, Sickinger S, Schmidt-Heck W, Buentemeyer H, Iding K, Lehmann J, Pfaff M, Pless G, Gerlach JC. Dynamics of amino acid metabolism of primary human liver cells in 3D bioreactors. Bioprocess Biosyst. Eng. 28: 331-40, 2006.